Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CUR wil be next SRPT..see PROPTHINK article today..very positive
forget the little muggets who exit and enter like worms thru wounds..big insitutions are listening and will start to load up. I saw few big blocks 100k etc going thru above 5 closer to ask.
FWIW, I am so confident on the HEAT resuls, I just finished direct rollout of my 401k account to TD Ameritrade IRA account today..they have made it so easy to do the transfer online now..will be buying boatful of CLSN shares on my IRA account come early next week. Cannot think of better timing.
Nov 2012 5's had some action today to the tune of 100 contracts at ask..vote of confidence for the pps to be over 5 by then..
On the CC, if MT indicates some big pharma partnership talks are in progress, we will be off to the race sooner than you think..
It depends on the strike price. If you are in 5 or even 6, you will be so deep ITM, the effect is owning the stock with relatively less capital. The PPS will be $20 regardless of PDUFA date.
Agree..Cramer's pump won't hurt either..
I expect the Monday CC to be very positive and if MT continues to show the level of excitment he showed on the last CC, we will be $10 by year end easy.. I also would expect upgrades to start rolling in..
The next big thing in Biotech..DVAX coverage by Adam F..
http://www.thestreet.com/_yahoo/video/11761138/the-next-big-thing-in-biotech-dynavax.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NA&s=1
News !!! 380 events confirmed...!
http://finance.yahoo.com/news/celsion-announces-phase-iii-heat-130000661.html
I don't blame you. Look at NPSP..similar pattern..I think the downtrend is mostly to do with capital gain tax going up next year (likely) and investors want to lock on to their gains..I am looking for biotechs that will do well not only going into 2013 but over 6 to 9 month horizon. I plan to average down barring any unexpected bad news which I don't see happening with DVAX..
I think we will jump back to high 4's once adcom meeting votes positively
Who am I to say otherwise ?
Eeeaahh ! I plan to take anywhere north of $25 on first jump..2nd leap for other indications (Dignity etc) will get us there but who knows..heck, $50 would be very very nice !!
Big bada boom prediction on HEAT results..
15 to 25 (control to treatment arms)..which gives ~70% improvement over RFA alone for TDOX+RFA..
Yeah watching..MF's article seems to have given some credibility
DVAX News
William Blair has a price target of $9 per share per report this AM.
http://seekingalpha.com/article/977731-analysts-at-william-blair-maintain-outperform-on-dynavax-technologies?source=yahoo
William Blair has a price target of $9 per share per report this AM.
http://seekingalpha.com/article/977731-analysts-at-william-blair-maintain-outperform-on-dynavax-technologies?source=yahoo
Good luck but I am holding still. 85% approval with positive vote has favorable odds.
Celsion Corporation to Hold Third Quarter 2012 Financial Results Conference Call on Monday, November 12, 2012
http://finance.yahoo.com/news/celsion-corporation-hold-third-quarter-120000989.html
DVAX definitely on a break-out going into Nov 14th ADCOMM meeting
DVAX definitely on the breakout going into Nov 14th ADCOM meeting
$heff, Just wanted to take a moment to acknowlege awesome board you have and excellent DDs available both by you & others who are lot more knowledgeable than I am. I am proud to say I have benefited on numerous occasions just by being a lurker and a big thanks for that. I plan to contribute where & when I can.
For those who still have doubts in the TDOX science, I would draw their attention to the 2Q webcast (still available on Celsion website). MT has repeated few times that there is no reason for the trail not to be positive. I expect the mood & tone to continue on the 3Q CC.
I suspect CLSN management will not be shy to hide any enthusiasm on the upcoming CC provided everything is going well as planned. They will use the CC opportunity especially the Q&A to support the stock. I hope most if not all, biopharmpr's questions get answered.
In short, CC is our next milestone
I wouldn't worry much..Why apr ? The results will be out by EOY..the call to put ratio for Jan 2013 are still way high indicating strong upside in Jan
In the past 6 years, approvals received through the 505(b)(2) pathway have consistently outnumbered "de novo" NDAs. http://bit.ly/ThPPE6
Highly relevant in CLSN situation as TDOX approval will be filed under 505 and fast tracked.
Great comments..
FWIW, there will be a cc early November and MT will confirm the results by EOY. MT will not miss the chance to be a hero.
The last thing CLSN managemet would want to do to is not to have 3Q CC or answer questions related to timing of data release on the CC call. Being public company, by regulations, they have to have 3Q PR followed by CC and just as the longs, it would be in the management interest to use this opportunity to beef up the PPS prior to 10 point jump once the results are out. JMHO
Amen ! I am pretty confident the CC will be upbeat..it's for no reason, MT has been talking about $1 billon dollar market
Great time & pps to load up, IMHO. Cowen's analyst is highly respected and looking at PIII results, the adcom will pass with majority votes. Another push by Cramer likely to happen before then in his lightning round,,that won't hurt either...lol
DVAX is gearing up for a climb for the upcoming ADCOM meeting
Looks like Dr.Phil Nadeau who covers DVAX is highly respected on the street.
http://www.cowen.com/ResearchCoverage.asp?target=AnalystByIndustry&IndustryName=Health+Care&IndustryID=-258
Great SA article.. 85% probability of approval
http://seekingalpha.com/article/948531-85-probability-of-fda-approval-for-dynavax-s-heplisav-says-cowen-s-senior-analyst?source=email_rt_article_title&ifp=0
All true It's indeed rare that a small biotech company such as Celsion has not make mistakes or forecasted the events with reasonable prediction & fairly enough. Though in the past such communications has not been prompt, look at the recent announcements starting with MT's letter & prediction of TDOX becoming $1 billion product. Also either he has balls of steel or very confident of the HEAT resuls to confirm that there are no secondary offerings are planned prior to the results.
I am waiting on the 3Q CC..if I contiue to see the upbeat mood on the part of management team, I am going to bet my farm..lol
DVAX has hit the bottom..
Insiders cannot sell in such situations (quiet period) unless they want to go to jail
That's near impossible as the double blinded data has to be tabluated at a central location from all over the clinical sites across the world. No individual sites will have a clue about others. Secondly a retail investor, even if they know such a 'news' unlikely to have necessary shares to drive the price down. I think this is what has happened:
1. This stock has been on the radar of retail investors for quite some time and most of them have been longs with considerable positions already taken.
2. Institutions won't buy this late in the game pending results.
3. With not much buying pressure, shorts grab such a situtation to hammer the pps as much as they can.
Speaking for myself, I wish I have more dry powder to add at these prices. Anyway. 3Q CC will be critical to ascertain the mood and tone of the Management team especially MT. Good luck to all longs
If I may chime in, actually BSDM news is good for CLSN. Imagine how effective the delivery and the 'double whammy' effect both hyperthermia+Tdox will bring to cancer tumors.
Thomson Reuters just now upgraded CLSN to Strong buy with $18 price target..sorry, no links..lol
No downgrade...what 19th ? post the link